Terri Pasquine

Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study

Mark B. Abelson, Paul J Gomes, Cullen T. Vogelson et al. · Clinical Therapeutics · 2004 · 42 citations

Ocular Disease, Allergy, Ophthalmology +8

Perception and quality of life associated with the use of olopatadine 0.2% (Pataday™) in patients with active allergic conjunctivitis

Stephen V. Scoper, Gregg J. Berdy, Steven J. Lichtenstein et al. · Advances in Therapy · 2007 · 25 citations

Asthma, Allergy, Ophthalmology +8

Preclinical and clinical antiallergic effect of olopatadine 0.2% solution 24 hours after topical ocular administration.

Cullen T. Vogelson, Mark B. Abelson, Terri Pasquine et al. · PubMed · 2004 · 23 citations

Ocular Disease, Allergy Medicine, Pharmacotherapy +16

Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis

Mark B. Abelson, Paul J Gomes, Cullen T. Vogelson et al. · Current Medical Research and Opinion · 2005 · 17 citations

Efficacy of olopatadine ophthalmic solution 0.2% in reducing signs and symptoms of allergic conjunctivitis

Mark B. Abelson, Paul J Gomes, Terri Pasquine et al. · Allergy and Asthma Proceedings · 2007 · 14 citations

New Formulation, Ocular Disease, Allergy +11